{"id":"CHEMBL1090771","canonicalSmiles":"NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(-c2ncon2)cc1F)S(=O)(=O)c1ccc(Cl)cc1","inchiKey":"XEAOPVUAMONVLA-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AVAGACESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avagacestat","BMS 708163","BMS-708163","BMS-708163-01","BMS-70816301"],"crossReferences":{"drugbank":["DB11893"]},"count":1,"linkedTargets":{"rows":["ENSG00000138613","ENSG00000205155","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1092824","canonicalSmiles":"O=C(Nc1nccs1)C(=O)NC1CCCC1","inchiKey":"BJHPYHUDDCVBNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1092824","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07591"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1098319","canonicalSmiles":"O=S(=O)(O)CCS","inchiKey":"ZNEWHQLOPFWXOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MESNA","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mesnex"],"synonyms":["D 7093","Mesna"],"crossReferences":{"DailyMed":["mesna"],"drugbank":["DB09110"],"chEBI":["17905"]},"childChemblIds":["CHEMBL975"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988."}
{"id":"CHEMBL119549","canonicalSmiles":"O=C(Nc1ccc(-c2nn[nH]n2)cc1)c1ccc(-c2nn[nH]n2)cc1","inchiKey":"VXEBMQZDPONDFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDOLAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Andolast","Cr2039"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1200601","canonicalSmiles":"CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1.Cl","inchiKey":"AWEZYKMQFAUBTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARATRIPTAN HYDROCHLORIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1278","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amerge","Naramig","Naratriptan"],"synonyms":["GR 85548A","GR-85548A","Naratriptan hydrochloride"],"crossReferences":{"DailyMed":["naratriptan%20hydrochloride"],"PubChem":["144207166","170465423"],"chEBI":["7479"]},"count":2,"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["HP_0012075","EFO_0003821","EFO_0000677","HP_0002315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 2 investigational indications."}
{"id":"CHEMBL1200696","canonicalSmiles":"[K+].[O-][Cl+3]([O-])([O-])[O-]","inchiKey":"YLMGFJXSLBMXHK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM PERCHLORATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Perchloracap","Peroidin","Pertiroid"],"synonyms":["Potassium perchlorate"],"crossReferences":{"DrugCentral":["4698"],"PubChem":["144212509"],"Wikipedia":["Potassium_perchlorate"],"drugbank":["DB09418"]},"count":1,"approvedIndications":["HP_0000820"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for abnormality of the thyroid gland."}
{"id":"CHEMBL1200823","drugType":"Small molecule","blackBoxWarning":false,"name":"IRON SUCROSE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Venofer"],"synonyms":["Ferric hydroxide sucrose complex","Iron oxide saccharated","Iron saccharate","Iron sucrose","Iron sucrose complex","Iron sugar","Iron(iii) hydroxide sucrose complex","Saccharated ferric oxide","Saccharated iron","Saccharated iron oxide","XI-921"],"crossReferences":{"DailyMed":["iron%20sucrose"]},"count":6,"approvedIndications":["EFO_0003884","EFO_0004272","HP_0001891"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 3 approved and 3 investigational indications."}
{"id":"CHEMBL1200827","canonicalSmiles":"Cl.O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21","inchiKey":"MKCBCZDNNZPMCG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MITOXANTRONE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL58","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL-232315"],"crossReferences":{"PubChem":["50122901","50122902","56424031","572869","85273759"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200845","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1","inchiKey":"MUQNGPZZQDCDFT-JNQJZLCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALCINONIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Halog","Halog-e"],"synonyms":["Halcinonide","SO 18566","SQ-18566"],"crossReferences":{"DailyMed":["halcinonide"],"PubChem":["144204081","170465389","56463097"],"Wikipedia":["Halcinonide"],"drugbank":["DB06786"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974."}
{"id":"CHEMBL1200893","canonicalSmiles":"CC(Cc1ccc2c(c1)OCO2)NCC(O)c1ccc(O)c(O)c1.Cl","inchiKey":"LOVXREQUMZKFCM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOKYLOL HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201273","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ventaire"],"synonyms":["Protokylol HCl","Protokylol hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200914","canonicalSmiles":"CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1.Cl","inchiKey":"ZZIZZTHXZRDOFM-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAMSULOSIN HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL836","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphacard mr","Bazetham mr","Contiflo xl","Cositam xl","Diffundox","Faramsil","Flectone xl","Flomax","Flomax mr","Flomax relief mr","Flomaxtra xl","Galebon","Losinate mr","Maxtron","Morvesin xl","Omnic mr","Pamsvax xl","Petyme","Pinexel pr","Prosurin xl","Stronazon","Tabphyn mr","Tamfrex xl","Tamsulosin hydrochloride","Tamurex"],"synonyms":["LY-253351","LY253351","R-(-)-YM-12617","Tamsulosin hydrochloride","YM-12617-1","YM-617","YM617"],"crossReferences":{"DailyMed":["tamsulosin%20hydrochloride"],"PubChem":["144205999","170464826"],"chEBI":["9399"]},"count":6,"approvedIndications":["EFO_0000284","EFO_0001663"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["HP_0000016","EFO_0004253","EFO_0005323","EFO_1001228","EFO_0000284","EFO_0000536","EFO_0003830","HP_0000011","EFO_0001663","EFO_0000537","HP_0011277"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for prostate carcinoma and benign prostatic hyperplasia and has 4 investigational indications."}
{"id":"CHEMBL1200946","canonicalSmiles":"CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C","inchiKey":"JKWKMORAXJQQSR-MOPIKTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NANDROLONE DECANOATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Deca-durabolin","Durabolin","Nandrolone decanoate"],"synonyms":["Nandrolone decanoate","Nandrolone decanoate ciii"],"crossReferences":{"PubChem":["144205191","170464711","29215336"],"drugbank":["DB08804"],"chEBI":["7467"]},"count":4,"approvedIndications":["EFO_0003966"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003966","EFO_0007312","EFO_0008572","EFO_0003964"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for eye disease and has 3 investigational indications."}
{"id":"CHEMBL1201038","canonicalSmiles":"CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc2ccccc12","inchiKey":"YZODJQFXMFEJRM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACRISORCIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akrinol"],"synonyms":["Acrisorcin","SCH 7056","SCH-7056"],"crossReferences":{"DrugCentral":["5103"],"PubChem":["26748936"],"Wikipedia":["Acrisorcin"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201528","drugType":"Protein","blackBoxWarning":false,"name":"VASOPRESSIN TANNATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pitressin tannate"],"synonyms":["Vasopressin tannate"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201543","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Novolin l"],"synonyms":["Insulin zinc susp semisynthetic purified human"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL1201627","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Insulatard nph human","Novolin n"],"synonyms":["Insulin susp isophane semisynthetic purified human"],"count":5,"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0001645","HP_0003074","HP_0004326","EFO_0001360","EFO_0000400","EFO_0000537"],"count":8},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 5 investigational indications."}
{"id":"CHEMBL1201648","drugType":"Enzyme","blackBoxWarning":false,"name":"AMYLASE (PANCRELIPASE)","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Amylase","Amylase (pancrelipase)","E1100"],"crossReferences":{"DailyMed":["amylase%20(pancrelipase)"]},"count":1,"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1996 and has 1 investigational indication."}
{"id":"CHEMBL1205969","canonicalSmiles":"O=C(O)CCO","inchiKey":"ALRHLSYJTWAHJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1205969","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03688"],"chEBI":["33404"]},"childChemblIds":["CHEMBL171409"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1208155","canonicalSmiles":"COc1cccc(-c2c(C)n(Cc3c(F)cccc3C(F)(F)F)c(=O)n(C[C@H](NCCCC(=O)O)c3ccccc3)c2=O)c1F","inchiKey":"HEAUOKZIVMZVQL-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELAGOLIX","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Elagolix","NBI-56418"],"crossReferences":{"DailyMed":["elagolix%20sodium"],"drugbank":["DB11979"]},"childChemblIds":["CHEMBL502182"],"count":2,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000731","EFO_0001065","EFO_0000660"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 2 investigational indications."}
{"id":"CHEMBL121626","canonicalSmiles":"Cc1c(Cl)cccc1Nc1ccccc1C(=O)O","inchiKey":"YEZNLOUZAIOMLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOLFENAMIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clotam","Clotam rapid"],"synonyms":["Tolfenamic acid"],"crossReferences":{"PubChem":["104171320","11112613","144204121","170465638","26746981","855759"],"Wikipedia":["Tolfenamic_acid"],"drugbank":["DB09216"],"chEBI":["32243"]},"count":3,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 2 investigational indications."}
{"id":"CHEMBL121663","canonicalSmiles":"Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21.[Cl-].[Cl-]","inchiKey":"LTNZEXKYNRNOGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEQUALINIUM CHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL333826","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dequacets","Dequadin","Fluomizin","Labosept"],"synonyms":["BAQD 10","BAQD-10","Dequalinium chloride","GNF-PF-5483","NSC-166454"],"crossReferences":{"PubChem":["144203679","26747489","26747490","50106101"],"Wikipedia":["Dequalinium"],"chEBI":["31466"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1230628","canonicalSmiles":"Nc1nc2c([nH]c(=O)n2[C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1","inchiKey":"HCAJQHYUCKICQH-VPENINKCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230628","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02502"],"chEBI":["40304"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230893","canonicalSmiles":"CC(=O)NCCc1c[nH]cn1","inchiKey":"XJWPISBUKWZALE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230893","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49674566"],"drugbank":["DB04622"],"chEBI":["28483"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231023","canonicalSmiles":"N[C@H](CP(=O)(O)O)C(=O)O","inchiKey":"LBTABPSJONFLPO-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231023","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110745","11113385"],"drugbank":["DB03292"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232261","canonicalSmiles":"CS(=O)(=O)c1cccc(-c2cc(N3C[C@H](c4cc(F)c(F)cc4F)[C@@H](N)C3)ncn2)c1","inchiKey":"OAWGQHXWGXOUKV-BEFAXECRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232261","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07666"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232804","canonicalSmiles":"O=C(NCP(=O)(O)O)OCc1ccccc1","inchiKey":"WUNKRZNFNIYEPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(BENZYLOXYCARBONYLAMINO)METHYLPHOSPHONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02642"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232952","canonicalSmiles":"C=C1C[C@]23C[C@@]1(O)CC[C@H]2[C@@]12C=C[C@H](O)[C@@](C)(C(=O)O1)[C@H]2[C@@H]3C(=O)O","inchiKey":"IXORZMNAPKEEDV-OBDJNFEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GIBBERELLIN A3","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+)-Gibberellic Acid"],"crossReferences":{"PubChem":["144209250","144213340","49826122","56463589","78420"],"drugbank":["DB07814"],"chEBI":["28833"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233202","canonicalSmiles":"C[C@@H](Oc1ccc(Oc2ncc(C(F)(F)F)cc2Cl)cc1)C(=O)O","inchiKey":"GOCUAJYOYBLQRH-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOXYFOP-R-METHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07870"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234524","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C[C@](Oc2ccc3c(C)cc(=O)oc3c2)(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CO","inchiKey":"KKDWIUJBUSOPGC-GKHMPSLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234524","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234579","canonicalSmiles":"N#[N+][O-]","inchiKey":"GQPLMRYTRLFLPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITROUS OXIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Entonox"],"synonyms":["E-942","FEMA NO. 2779","INS NO.942","INS-942","Nitrogen monoxide","Nitrous Oxide","Nitrous oxide"],"crossReferences":{"Wikipedia":["Nitrous_oxide"],"drugbank":["DB06690"],"chEBI":["17045"]},"count":16,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL1235931","canonicalSmiles":"CC(=O)CCC(=O)O","inchiKey":"JOOXCMJARBKPKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVULINIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FEMA NO. 2627","Levulinic acid","NSC-3716"],"crossReferences":{"PubChem":["144208681","144213046","29217860"],"Wikipedia":["Levulinic_acid"],"drugbank":["DB02239"],"chEBI":["45630"]},"childChemblIds":["CHEMBL3707302","CHEMBL3186421","CHEMBL2106516"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1236196","canonicalSmiles":"CCCC[N+](CCCC)(CCCC)CCCC","inchiKey":"DZLFLBLQUQXARW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRABUTHYLAMMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetrabuthylammonium"],"crossReferences":{"drugbank":["DB01851"],"chEBI":["45825"]},"childChemblIds":["CHEMBL60696","CHEMBL1078808","CHEMBL1079205","CHEMBL1079247","CHEMBL1079248","CHEMBL1078938","CHEMBL1077952","CHEMBL1078613","CHEMBL1079159","CHEMBL1078071","CHEMBL1078826","CHEMBL1078233","CHEMBL1078150","CHEMBL2115068","CHEMBL1078326","CHEMBL1078612","CHEMBL1078154","CHEMBL1078234","CHEMBL1077846"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL125381","canonicalSmiles":"Cc1cc(-n2ncc(=O)[nH]c2=O)cc(C)c1Oc1ccc(O)c(C(C)C)c1","inchiKey":"RXQAVKWRCZYGMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL125381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03181"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256688","canonicalSmiles":"COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C.Cl","inchiKey":"UKGWRIXCWLUSJF-OCPPCWRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1256688","maximumClinicalTrialPhase":0,"parentId":"CHEMBL45816","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1288810","canonicalSmiles":"OC[C@@H](O)CN1CCN(c2ccccc2)CC1","inchiKey":"PTVWPYVOOKLBCG-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVODROPROPIZINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dropropizine s-form","Levodropropizine"],"crossReferences":{"PubChem":["11112639"],"drugbank":["DB12472"],"chEBI":["82722"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL135626","canonicalSmiles":"CC","inchiKey":"OTMSDBZUPAUEDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHANE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethane","Venoterpine"],"crossReferences":{"Wikipedia":["Ethane"],"chEBI":["42266"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL138241","canonicalSmiles":"CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.[Na+]","inchiKey":"WVKIYGXHDKTNFO-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOPROFEN SODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1297","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fenoprofen Sodium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL13968","canonicalSmiles":"CCCCN","inchiKey":"HQABUPZFAYXKJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Aminobutane","NBA"],"crossReferences":{"PubChem":["144211448"],"Wikipedia":["N-Butylamine"],"drugbank":["DB03659"],"chEBI":["43799"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1591","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12","inchiKey":"FMTDIUIBLCQGJB-SEYHBJAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEMECLOCYCLINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Demeclocycline","Demethylchlortetracycline"],"crossReferences":{"DailyMed":["demeclocycline%20hydrochloride"],"PubChem":["90341625"],"Wikipedia":["Demeclocycline"],"drugbank":["DB00618"],"chEBI":["4392"]},"childChemblIds":["CHEMBL1200474"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1615374","canonicalSmiles":"Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1","inchiKey":"RPZBRGFNBNQSOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VILAZODONE HYDROCHLORIDE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL439849","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Viibryd"],"synonyms":["EMD 68 843","EMD-68843","SB-659746-A","SB659746-A","Vilazodone hydrochloride"],"crossReferences":{"DailyMed":["vilazodone%20hydrochloride"],"chEBI":["70705"]},"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000178394"],"count":2},"linkedDiseases":{"rows":["MONDO_0002050","EFO_0003761","EFO_0001358"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2011 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1619","canonicalSmiles":"Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1","inchiKey":"PTOAARAWEBMLNO-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLADRIBINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cladribine","Leustat","Leustatin","Litak","Mavenclad"],"synonyms":["Cladaribine","Cladribine","Leustatin","NSC-05014","NSC-105014","NSC-105014-F","RWJ 26251","RWJ-26251"],"crossReferences":{"DailyMed":["cladribine"],"PubChem":["124886798","144204385","144210913","26719669","26757803","50104045","56422184","855756","866156"],"Wikipedia":["Cladribine"],"drugbank":["DB00242"],"chEBI":["567361"]},"count":24,"approvedIndications":["EFO_0000616","EFO_0000540"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for immune system disease and neoplasm and has 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL16300","canonicalSmiles":"O=C(NO)c1ccccc1","inchiKey":"VDEUYMSGMPQMIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOHYDROXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benzhydroxamic acid","Benzohydroxamate","N-hydroxybenzamide","benzoyl hydroxamic acid"],"crossReferences":{"PubChem":["124890367","144214021","17388860"],"drugbank":["DB01924"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1631694","canonicalSmiles":"CSc1ccc(OCc2ncc([N+](=O)[O-])n2C)cc1","inchiKey":"MIWWSGDADVMLTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEXINIDAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fexinidazole","HOE 239","HOE-239"],"crossReferences":{"drugbank":["DB12265"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL1688530","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O","inchiKey":"VHFGEBVPHAGQPI-LXKZPTCJSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"ORITAVANCIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LY-333328","LY333328","Oritavancin"],"crossReferences":{"DailyMed":["oritavancin%20diphosphate"],"drugbank":["DB04911"],"chEBI":["82699"]},"childChemblIds":["CHEMBL3989766"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for bacterial disease."}
{"id":"CHEMBL1697741","canonicalSmiles":"CCC1=C(C[C@H]2NCCc3cc(OC)c(OC)cc32)C[C@H]2c3cc(OC)c(OC)cc3CCN2C1","inchiKey":"XXLZPUYGHQWHRN-RPBOFIJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEHYDROEMETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dehydroemetine","RO 1-9334/19"],"crossReferences":{"drugbank":["DB13865"],"chEBI":["4363"]},"childChemblIds":["CHEMBL1977229"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL169896","canonicalSmiles":"Cc1nc2ccc3ccc(CNc4ccc5c(c4)CN([C@@H](CCC(=O)O)C(=O)O)C5=O)cc3c2c(=O)[nH]1","inchiKey":"BRVFNEZMTRVUGW-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSI-7904","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OSI-7904L","Osi 7904","Osi 7904l","Osi-7904","Osi-7904l","TCMDC-131928"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL170797","canonicalSmiles":"CCOC(=O)C1(c2ccccc2)CCCN(C)CC1","inchiKey":"WGJHHMKQBWSQIY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOHEPTAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethoheptazine"],"crossReferences":{"Wikipedia":["Ethoheptazine"],"drugbank":["DB08988"]},"childChemblIds":["CHEMBL3186813","CHEMBL1201887"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742987","drugType":"Antibody","blackBoxWarning":false,"name":"ATINUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-355","Atinumab"],"linkedTargets":{"rows":["ENSG00000115310"],"count":1},"linkedDiseases":{"rows":["EFO_1001919"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743010","drugType":"Antibody","blackBoxWarning":false,"name":"ELOTUZUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BMS-901608","Elotuzumab","HULUC63","PDL-063","PDL063"],"crossReferences":{"DailyMed":["elotuzumab"],"DrugCentral":["5072"]},"count":6,"approvedIndications":["EFO_0000616","EFO_0001378"],"linkedTargets":{"rows":["ENSG00000026751"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003073","EFO_0006475","EFO_0001378","MONDO_0044881","Orphanet_85443"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for multiple myeloma and neoplasm and has 4 investigational indications."}
{"id":"CHEMBL1756","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OC(=O)N(CCCl)CCCl)cc4CC[C@H]3[C@@H]1CC[C@@H]2OP(=O)(O)O","inchiKey":"ADFOJJHRTBFFOF-RBRWEJTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRAMUSTINE PHOSPHATE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estracyt"],"synonyms":["Estramustine 17-(dihydrogen phosphate)","Estramustine phosphate","NSC-89199"],"crossReferences":{"DailyMed":["estramustine%20phosphate%20sodium"],"PubChem":["144206584"],"drugbank":["DB14674"],"chEBI":["68643"]},"childChemblIds":["CHEMBL1200721"],"count":1,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","EFO_0000574","MONDO_0007254","MONDO_0002367","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1981 and has 1 investigational indication."}
{"id":"CHEMBL176045","canonicalSmiles":"COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3","inchiKey":"WVTKBKWTSCPRNU-KYJUHHDHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FANCHININ","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-77037"],"crossReferences":{"PubChem":["118059","124883161","124883162","124883163","124883165","26725273","26754345","26754346","398101","56463074"],"Wikipedia":["Tetrandrine"],"drugbank":["DB14066"],"chEBI":["49"]},"childChemblIds":["CHEMBL4160643"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1783282","canonicalSmiles":"CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N","inchiKey":"KYDURMHFWXCKMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD7325","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd7325"],"crossReferences":{"drugbank":["DB13994"]},"count":3,"linkedTargets":{"rows":["ENSG00000011677","ENSG00000151834"],"count":2},"linkedDiseases":{"rows":["EFO_0003756","EFO_0005230","Orphanet_908"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1788133","canonicalSmiles":"Cl.NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl","inchiKey":"NXDBFIUCDBZBPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FUROSEMIDE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL35","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["furosemide"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1788393","canonicalSmiles":"CCOCCN(Cc1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1)C(=O)C(Cl)Cl","inchiKey":"QTRALMGDQMIVFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethylchlordiphene","Etofamide"],"crossReferences":{"drugbank":["DB13258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18901","canonicalSmiles":"Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1","inchiKey":"BNFRJXLZYUTIII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFAPROXIRAL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Efaproxiral","RSR-13","RSR13"],"crossReferences":{"Wikipedia":["Efaproxiral"],"drugbank":["DB08486"]},"childChemblIds":["CHEMBL2107744"],"count":4,"linkedTargets":{"rows":["ENSG00000244734","ENSG00000188536","ENSG00000206172"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008903","MONDO_0007254","MONDO_0024880","EFO_1000158"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1908305","canonicalSmiles":"C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@H]3CC[S@@+]([O-])C3)S[C@H]12","inchiKey":"FLSUCZWOEMTFAQ-PRBGKLEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULOPENEM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-70,429","CP-70429","Sulopenem"],"crossReferences":{"drugbank":["DB15284"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1909080","canonicalSmiles":"O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]","inchiKey":"AMGRXJSJSONEEG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM CHLORIDE HEXAHYDRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2219640","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Strontium Chloride Hexahydrate"],"crossReferences":{"chEBI":["36385"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL192","canonicalSmiles":"CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12","inchiKey":"BNRNXUUZRGQAQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILDENAFIL","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nipatra","Revatio","Viagra","Vizarsin"],"synonyms":["HIP-0908","HIP0908","Sildenafil","UK-92480"],"crossReferences":{"DailyMed":["sildenafil%20citrate"],"PubChem":["26748898","50085897"],"drugbank":["DB00203"],"chEBI":["9139"]},"childChemblIds":["CHEMBL1737"],"count":50,"approvedIndications":["EFO_0004234","HP_0000802"],"linkedTargets":{"rows":["ENSG00000138735"],"count":1},"linkedDiseases":{"rows":["EFO_0008493","MONDO_0024647","EFO_0001361","EFO_0003777","Orphanet_98895","EFO_0009197","HP_0000802","EFO_0000266","HP_0001298","EFO_1001145","EFO_0003913","EFO_0004714","EFO_1000824","EFO_1001134","EFO_0005295","EFO_0009429","EFO_0000400","EFO_0000692","Orphanet_654","EFO_0009441","EFO_0000198","MONDO_0005149","HP_0200042","EFO_1001103","EFO_0002508","EFO_0008560","HP_0001919","EFO_0009085","MONDO_0002013","EFO_0000701","MONDO_0008315","Orphanet_98896","EFO_0001422","EFO_0000404","MONDO_0100096","HP_0100607","EFO_0000341","EFO_0003830","EFO_0000516","EFO_0004225","EFO_0000668","MONDO_0021640","EFO_0006862","EFO_0001365","Orphanet_232","EFO_0000768","EFO_0004234","EFO_0000464","Orphanet_586","EFO_0000373","EFO_0000284","EFO_0000495","MONDO_0004933","EFO_1000783","Orphanet_70589","EFO_0003144","EFO_0000712","EFO_1001996","HP_0000618","EFO_0003047","EFO_0003917","EFO_1001893","EFO_0002546","EFO_0000717","EFO_0000616","EFO_1001017","EFO_0000545","HP_0002140","Orphanet_422","EFO_0001645","EFO_0009200","HP_0001655","HP_0200023","EFO_0003818","EFO_0001073","EFO_0003060","EFO_0000537","EFO_1000954","EFO_0000195","EFO_1001827","EFO_0003827","HP_0000020","HP_0025116","MONDO_0043510","EFO_0000519","EFO_0004540","EFO_0004265","EFO_1000899"],"count":88},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for erectile dysfunction and impotence and has 48 investigational indications."}
{"id":"CHEMBL1941138","canonicalSmiles":"C[C@@H](OP(=O)(O)O)C(=O)O","inchiKey":"CSZRNWHGZPKNKY-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-2-(Phosphonatooxy)Propanoate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-2-(Phosphonatooxy)Propanoate"],"crossReferences":{"drugbank":["DB01733"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1944785","canonicalSmiles":"CCN(CC)C(=O)[C@H]1CCCc2c1c1c(OC)cccc1n2CC[18F]","inchiKey":"ZVDVQPLDTTXLKI-LSKWOKDISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1944785","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2068835","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15380"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1963502","canonicalSmiles":"C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1","inchiKey":"XRYJULCDUUATMC-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PKI-166","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGP-75166","NVP-PKI166","PKI-166","Pki-166"],"childChemblIds":["CHEMBL1914653"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2017179","canonicalSmiles":"Cc1cc(C)c2c(c1)[C@@H](N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1)CCCN2C[C@H]1CC[C@H](C(=O)O)CC1","inchiKey":"IHIUGIVXARLYHP-YBXDKENTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVACETRAPIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evacetrapib","LY-2484595","LY2484595"],"crossReferences":{"Wikipedia":["Evacetrapib"],"drugbank":["DB11655"]},"count":4,"linkedTargets":{"rows":["ENSG00000087237"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0000319","EFO_0003774","Orphanet_309005"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL202311","canonicalSmiles":"O=c1c2ccccc2oc2ccc(S(=O)(=O)N=c3[nH]nn[nH]3)cc12","inchiKey":"HJWYZPGYPZNDTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202311","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04698"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2068971","canonicalSmiles":"C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@]1(O)CC[C@]2(O)c1ccoc1","inchiKey":"AEAPORIZZWBIEX-DTBDINHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROSTAFUROXIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rostafuroxin"],"crossReferences":{"drugbank":["DB12350"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL207225","canonicalSmiles":"O=C(O)CCc1c[nH]c2ccccc12","inchiKey":"GOLXRNDWAUTYKT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOLYLPROPIONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Indolepropionicacid","Indole-3-Propionic Acid"],"crossReferences":{"drugbank":["DB02758"],"chEBI":["43580"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2079587","canonicalSmiles":"C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"LKAJKIOFIWVMDJ-IYRCEVNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STANOZOLOL","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Stromba","Tevabolin","Winstrol"],"synonyms":["Stanozolol","WIN 14833","WIN-14833","Winstrol","Winstrol Depot"],"crossReferences":{"PubChem":["170465251"],"drugbank":["DB06718"],"chEBI":["9249"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL2095222","drugType":"Enzyme","blackBoxWarning":false,"name":"OCRIPLASMIN","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["MICROPLASMIN","Ocriplasmin"],"crossReferences":{"DailyMed":["ocriplasmin"],"DrugCentral":["5004"]},"count":7,"approvedIndications":["EFO_0003966"],"linkedTargets":{"rows":["ENSG00000115414","ENSG00000172037","ENSG00000060718","ENSG00000130702","ENSG00000168542","ENSG00000188153","ENSG00000164692","ENSG00000206384","ENSG00000204262","ENSG00000169031","ENSG00000196569","ENSG00000172752","ENSG00000112769","ENSG00000050555","ENSG00000197565","ENSG00000142173","ENSG00000058085","ENSG00000204291","ENSG00000130635","ENSG00000171502","ENSG00000091128","ENSG00000139219","ENSG00000196878","ENSG00000101680","ENSG00000134871","ENSG00000108821","ENSG00000204248","ENSG00000163359","ENSG00000142156","ENSG00000081052","ENSG00000080573","ENSG00000053747","ENSG00000215018","ENSG00000091136","ENSG00000135862","ENSG00000196739","ENSG00000182871","ENSG00000187498"],"count":38},"linkedDiseases":{"rows":["EFO_0009606","EFO_0003966","EFO_1001231","EFO_1001028","EFO_0000712","EFO_1001157","EFO_0003907","EFO_0009321"],"count":8},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for eye disease and has 6 investigational indications."}
{"id":"CHEMBL2104745","canonicalSmiles":"CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1","inchiKey":"HIUPRQPBWVEQJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAGOCLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IP 456","IP-456","Pagoclone","RP 62955","RP-62955"],"crossReferences":{"drugbank":["DB04903"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105636","canonicalSmiles":"CC(=O)O.CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](C)O)C(=O)N1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@H](C)O)[C@H](C)O","inchiKey":"NVUKDWGDTWGJSK-QDABQXQZSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DAVALINTIDE ACETATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105635","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC2307","Davalintide acetate"],"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105734","canonicalSmiles":"COCC[n+]1c2c(n(Cc3cnccn3)c1C)C(=O)c1ccccc1C2=O.[Br-]","inchiKey":"QBIYUDDJPRGKNJ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SEPANTRONIUM BROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110734","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sepantronium bromide","YM 155","YM-155","YM155"],"count":8,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2106179","canonicalSmiles":"O=C1CC[C@H](C(=O)N2CCCCC2)N1","inchiKey":"GOWRRBABHQUJMX-MRVPVSSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FASORACETAM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEVI-001","Aevi-001","Fasoracetam","LAM-105","NS-105"],"crossReferences":{"PubChem":["144206891"],"chEBI":["31592"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106755","canonicalSmiles":"O=C([O-])c1ccccc1O.O=C([O-])c1ccccc1O.[Mg+2]","inchiKey":"MQHWFIOJQSCFNM-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"DrugCentral":["4510"],"drugbank":["DB01397"],"chEBI":["6640"]},"childChemblIds":["CHEMBL3989810"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106798","canonicalSmiles":"CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O","inchiKey":"CLUKHUGGXSIGRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NERAMEXANE MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110954","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neramexane mesilate","Neramexane mesylate"],"count":1,"linkedTargets":{"rows":["ENSG00000161509","ENSG00000273079","ENSG00000183454","ENSG00000116032","ENSG00000105464","ENSG00000174343","ENSG00000129749","ENSG00000176884","ENSG00000198785"],"count":9},"linkedDiseases":{"rows":["HP_0000360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106915","canonicalSmiles":"COc1cc2c(cc1OC)C(CCc1ccc(Cl)cc1)N(C)CC2","inchiKey":"YBCPYHQFUMNOJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOPHOLINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"year":1965},"tradeNames":[],"synonyms":["ARC I-K-1","Methopholine","Metofoline","NIH 7672","RO 4-1778/1"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1965."}
{"id":"CHEMBL2107106","canonicalSmiles":"C#CC(C)(CC)OC(=O)c1ccccc1C(=O)O","inchiKey":"CZGIRAWWWHPJHM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHTHALOFYNE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ftalofyne","Phthalofyne"],"crossReferences":{"PubChem":["170466477"],"drugbank":["DB11449"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107560","canonicalSmiles":"O.O.O=P([O-])([O-])O.[Na+].[Na+]","inchiKey":"KDQPSPMLNJTZAL-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHOSPHATE, DIBASIC","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1060","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Sodium phosphate, dibasic","Sodium phosphate, dibasic, heptahydrate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL2107723","canonicalSmiles":"COc1cc(O)c(C(=O)Nc2nc(C(=O)NCCN(C(C)C)C(C)C)cs2)cc1OC","inchiKey":"TWHZNAUBXFZMCA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOTIAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acotiamide"],"crossReferences":{"drugbank":["DB12482"],"chEBI":["34523"]},"childChemblIds":["CHEMBL2107308"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0008533"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2107772","canonicalSmiles":"C[C@@H](c1ccc(-c2ccccc2)c(F)c1)c1cc(NC(=N)N2CCOCC2)on1","inchiKey":"MYTIJGWONQOOLC-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMACALIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rimacalib","SMP-114","Smp-114"],"crossReferences":{"drugbank":["DB12571"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2107884","drugType":"Antibody","blackBoxWarning":true,"name":"RESLIZUMAB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cinqaero","Cinqair","Cinquil"],"synonyms":["CEP-38072","DCP 835","DCP-835","Reslizumab","SCH 55700","SCH-55700","SCH55700"],"crossReferences":{"DailyMed":["reslizumab"],"DrugCentral":["5093"]},"count":8,"approvedIndications":["HP_0006536","EFO_0000270"],"linkedTargets":{"rows":["ENSG00000113525"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","MONDO_0004938","HP_0006536","EFO_0007486","EFO_1000729","EFO_0000270","EFO_0009661","EFO_1001467"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for airway obstruction and asthma and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108035","drugType":"Unknown","blackBoxWarning":true,"name":"INCOBOTULINUMTOXINA","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Incobotulinumtoxina","RTI-150","RTI150"],"count":15,"linkedTargets":{"rows":["ENSG00000132639"],"count":1},"linkedDiseases":{"rows":["HP_0001257","HP_0001337","EFO_1001219","HP_0000486","Orphanet_93955","HP_0012076","MONDO_0003441","EFO_0002508","EFO_0003821","HP_0000473","HP_0009762","EFO_0005422","EFO_0003843","Orphanet_1866","EFO_1001909","EFO_1000760","EFO_0000712","HP_0000975","EFO_1000781","HP_0002061","HP_0006986","EFO_0003877","HP_0025267","EFO_0003108"],"count":24},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108314","drugType":"Protein","blackBoxWarning":false,"name":"NEPIDERMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epidermal growth factor","Nepidermin"],"count":5,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108506","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Interf","Roferon-a","Viraferon","Wellferon"],"synonyms":["Interferon alfa","Interferon alfa natural","Interferon alpha"],"count":42,"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and has 42 investigational indications."}
{"id":"CHEMBL2108531","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIFEPROSAN 20","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Polifeprosan","Polifeprosan 20"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108875","drugType":"Unknown","blackBoxWarning":false,"name":"TETANUS TOXOID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetanus toxoid"],"count":20,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 20 investigational indications."}
{"id":"CHEMBL2108904","drugType":"Unknown","blackBoxWarning":false,"name":"BATROXOBIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Batroxobin"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109229","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"OBLIMERSEN SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Genasense"],"synonyms":["D-G3139","G-3139","G3139","Oblimersen","Oblimersen sodium"],"count":28,"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 28 investigational indications."}
{"id":"CHEMBL2109357","drugType":"Antibody","blackBoxWarning":false,"name":"AVE-1642","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVE-1642","AVE1642","Ave 1642","Ave-1642"],"count":3,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0018531","EFO_0001378"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109370","drugType":"Antibody","blackBoxWarning":false,"name":"T84.66","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T84.66"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109456","drugType":"Antibody","blackBoxWarning":false,"name":"QUILIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-M1","Anti-M1 prime","Anti-M1'","MEMP-1972A","MEMP1972A","MEP-1972A","MEP1972A","Quilizumab","RG-7449"],"count":3,"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005531","EFO_0000270"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110367","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC.O=S(=O)(O)O","inchiKey":"UILMMYFRNCCPLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOPRIM SULFATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL22","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BW 72U","Trimethoprim sulfate"],"crossReferences":{"DailyMed":["trimethoprim%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988."}
{"id":"CHEMBL2111086","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)C(=O)N[C@@H](C(=O)O)c1ccccc1)C(=O)O","inchiKey":"OJLHWPALWODJPQ-QNWVGRARSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANFOSFAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Canfosfamide"],"crossReferences":{"drugbank":["DB04972"]},"childChemblIds":["CHEMBL2107319"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2146083","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"AMEXZRFCGITZNZ-HZQSTTLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUININE BISULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Quinine bisulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2147708","canonicalSmiles":"Br.Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1","inchiKey":"ZBCRQDMAUHALHD-FKLPMGAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2147708","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2147777","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2180602","canonicalSmiles":"CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21","inchiKey":"KGSRYTUWXUESJK-FXBPSFAMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFETINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SIM 010603","SIM-010603","Tafetinib"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2181932","canonicalSmiles":"Cc1c(C(=O)Nc2ccc(S(C)(=O)=O)cc2)cn(CCO)c1-c1ccccc1C(F)(F)F","inchiKey":"NOSNHVJANRODGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2181932","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL221542","canonicalSmiles":"CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C","inchiKey":"KZJWDPNRJALLNS-VJSFXXLFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETA-SITOSTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["b-Sitosterol","beta-Sitosterol"],"crossReferences":{"PubChem":["144205067","73808"],"Wikipedia":["Beta-Sitosterol"],"drugbank":["DB14038"],"chEBI":["27693"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222476","canonicalSmiles":"CSc1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1","inchiKey":"ZIGJZZDDPXRGTL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL222476","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04720"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2311028","canonicalSmiles":"Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl.c1cc(CN2CCCNCCNCCCNCC2)ccc1CN1CCCNCCNCCCNCC1","inchiKey":"UEUPDYPUTTUXLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLERIXAFOR OCTAHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL18442","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMD-3100","Plerixafor Octahydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2331681","canonicalSmiles":"CCNC(=O)Nc1ccc(-c2nc3c(c(N4CCOC[C@@H]4C)n2)CCN(C2COC2)C3)cc1.CS(=O)(=O)O","inchiKey":"BQKCQDXRYRKGLX-NTISSMGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2331681","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2331680","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364651","drugType":"Antibody","blackBoxWarning":false,"name":"TOVETUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-575","Tovetumab"],"count":2,"linkedTargets":{"rows":["ENSG00000134853"],"count":1},"linkedDiseases":{"rows":["EFO_0000519","EFO_0000311"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2364652","drugType":"Antibody","blackBoxWarning":false,"name":"VANTICTUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OMP-18R5","Vantictumab"],"count":3,"linkedTargets":{"rows":["ENSG00000180340","ENSG00000177283","ENSG00000163251","ENSG00000155760","ENSG00000157240"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","MONDO_0007254"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL256892","canonicalSmiles":"CC(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)c1nc2ccccc2s1","inchiKey":"VXDAVYUFYPFGDX-SNPRPXQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RWJ-56423","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RWJ-56423"],"crossReferences":{"drugbank":["DB02812"]},"childChemblIds":["CHEMBL556199","CHEMBL124571"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267178","canonicalSmiles":"COc1ccc(S(=O)(=O)N(Cc2cccnc2)[C@@H](C(=O)NO)C(C)C)cc1","inchiKey":"BSIZUMJRKYHEBR-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CGS-27023A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CGS-27023A"],"crossReferences":{"drugbank":["DB07556"]},"childChemblIds":["CHEMBL514138"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279785","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C","inchiKey":"OCSMOTCMPXTDND-OUAUKWLOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MARIMASTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB 2516","BB-2516","GI 5712","GI-5712","KB-R 8898","Marimastat","TA 2516","TA-2516"],"crossReferences":{"PubChem":["136949642"],"Wikipedia":["Marimastat"],"drugbank":["DB00786"],"chEBI":["50662"]},"count":2,"linkedTargets":{"rows":["ENSG00000196611","ENSG00000149968","ENSG00000100985","ENSG00000262406","ENSG00000087245","ENSG00000137673"],"count":6},"linkedDiseases":{"rows":["MONDO_0008903","MONDO_0007254"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL283800","canonicalSmiles":"CN(CC(=O)O)C(=N)N","inchiKey":"CVSVTCORWBXHQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CREATINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Creatine","NSC-8752"],"crossReferences":{"Wikipedia":["Creatine"],"drugbank":["DB00148"],"chEBI":["16919"]},"count":12,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL284616","canonicalSmiles":"O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O","inchiKey":"CWVRJTMFETXNAD-JUHZACGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROGENIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorogenic acid","NSC-407296","NSC-70861"],"crossReferences":{"PubChem":["56463713"],"Wikipedia":["Chlorogenic_acid"],"drugbank":["DB12029"],"chEBI":["16112"]},"childChemblIds":["CHEMBL1590181"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL29188","canonicalSmiles":"COc1ccc(CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c(OC)c1OC","inchiKey":"JQSAYKKFZOSZGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOMERIZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lomerizine"],"crossReferences":{"PubChem":["26757962"],"Wikipedia":["Lomerizine"],"drugbank":["DB14065"]},"childChemblIds":["CHEMBL1404407","CHEMBL2356978"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL301213","canonicalSmiles":"O=C(Nc1nccs1)c1cccc(CN2C(=O)N(CC3CC3)[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@H]2Cc2ccccc2)c1","inchiKey":"HFLCERPZYCWLSZ-VKONIRKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL301213","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04609"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303457","canonicalSmiles":"N#Cc1ccc(NC(=S)NC(=N)Cc2c(Cl)cccc2Cl)cc1","inchiKey":"NWKJBFSBEAMDBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-100943","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-100943"],"crossReferences":{"drugbank":["DB07961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137339","drugType":"Cell","blackBoxWarning":false,"name":"ROMYELOCEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CLT-008","Romyelocel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3184906","canonicalSmiles":"CC=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccc(O)cc3)[C@H]2SC1.O","inchiKey":"ALYUMNAHLSSTOU-PFBPGKLMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPROZIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3301800","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cefprozil","Cefzil"],"synonyms":["BBS-1067","BMY-28100-03-800","BMY-28167","Cefprozil","Cefprozil e-form","Cefprozil monohydrate"],"crossReferences":{"DailyMed":["cefprozil"],"PubChem":["144205284"]},"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL324846","canonicalSmiles":"CCCCCCCC(=O)O","inchiKey":"WWZKQHOCKIZLMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTANOIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Caprylic acid","EDENOR C 8-98-100","FEMA NO. 2799","NSC-5024","Octanoic acid"],"crossReferences":{"PubChem":["144204596","144208477","144210663","17388833","17389655","85272331"],"Wikipedia":["Caprylic_acid"],"drugbank":["DB04519"],"chEBI":["28837"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3278065","canonicalSmiles":"[2H]C([2H])(C)N(CC)CC(=O)Nc1c(C)cccc1C","inchiKey":"NNJVILVZKWQKPM-BFWBPSQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3278065","maximumClinicalTrialPhase":0,"parentId":"CHEMBL79","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301670","canonicalSmiles":"CN(C)CC(C)(C)OC(=O)C(O)(c1ccccc1)c1ccccc1.Cl","inchiKey":"QRHDDSUGMIAILK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFEMERINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3304486","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"year":1986},"tradeNames":[],"synonyms":["Difemerine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in Germany  in 1986."}
{"id":"CHEMBL3348932","canonicalSmiles":"CC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1O)C(C)C","inchiKey":"DUXZAXCGJSBGDW-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESFESOTERODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Desfesoterodine"],"crossReferences":{"drugbank":["DB15578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL34062","canonicalSmiles":"COc1cc(OC)cc(-c2nc(N)c(CN)c(-c3ccc(Cl)cc3Cl)n2)c1","inchiKey":"RCJFINNFYUNFGH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL34062","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02004"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544912","canonicalSmiles":"Cl.NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1","inchiKey":"HEPUBAGOKRIZEO-PPPUBMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAXATRIGINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3544913","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CNV1014802A","GSK1014802A","Raxatrigine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544919","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)NCCCN1CCN(CCCNC(=O)[C@@H](N)CCCNC(=N)N)CC1","inchiKey":"HRDUUSCYRPOMSO-ROUUACIJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIRAPARANTAG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciraparantag","PER-977","PER977"],"crossReferences":{"drugbank":["DB15199"]},"childChemblIds":["CHEMBL3544918"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545020","drugType":"Small molecule","blackBoxWarning":false,"name":"MBX-2044","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mbx-2044"],"count":1,"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545086","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2881835","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2881835","LY2881835","Ly2881835"],"count":1,"linkedTargets":{"rows":["ENSG00000126266"],"count":1},"linkedDiseases":{"rows":["EFO_0001360"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545088","drugType":"Small molecule","blackBoxWarning":false,"name":"PUQUITINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xc-302"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545195","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-3009120","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DP-4978","LY3009120","Ly-3009120"],"count":4,"linkedTargets":{"rows":["ENSG00000078061","ENSG00000157764","ENSG00000132155"],"count":3},"linkedDiseases":{"rows":["EFO_0000756","EFO_0004142","EFO_0003060","EFO_0009708"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545210","canonicalSmiles":"CCN(CC)Cc1ccc(OCC[C@H]2CCC3C4C(CC[C@@]32C)c2ccc(O)cc2C[C@H]4C)c(OC)c1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"VOHOCSJONOJOSD-RQIKCBEZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SR16234","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3545211","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sr16234","TAS-108","TS-108"],"count":1,"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545240","drugType":"Small molecule","blackBoxWarning":false,"name":"CLX-0921","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clx-0921"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545265","drugType":"Small molecule","blackBoxWarning":false,"name":"MLN-0415","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mln-0415"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3547132","canonicalSmiles":"N[C@@H](Cc1cc(O)c(O)cc1F)C(=O)O","inchiKey":"PAXWQORCRCBOCU-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORODOPA","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fluorodopa"],"crossReferences":{"DailyMed":["fluorodopa%20f-18"],"chEBI":["49163"]},"childChemblIds":["CHEMBL3400972"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019 and has 1 investigational indication."}
{"id":"CHEMBL363392","canonicalSmiles":"CCCCC1(CCCC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2ccc(OCc3ccc(C[N+]45CCN(CC4)CC5)cc3)cc2)[C@H]1O","inchiKey":"STPKWKPURVSAJF-LJEWAXOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MARALIXIBAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LUM-001 CATION","LUM001 CATION","Maralixibat"],"childChemblIds":["CHEMBL17879"],"count":1,"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["Orphanet_30391","EFO_0004268","Orphanet_172","EFO_0001421","Orphanet_52","EFO_1001486"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL363449","canonicalSmiles":"CC1CCc2c(N3CCC(O)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"JYJTVFIEFKZWCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NADIFLOXACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nadifloxacin","OPC 7251","OPC-7251"],"crossReferences":{"PubChem":["144205792","170465882","26758042","56463184"],"drugbank":["DB12447"],"chEBI":["31889"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707223","canonicalSmiles":"CCOC(=O)C[N+]1(C)CC[C@@H](OC(=O)[C@](O)(c2ccccc2)C2CCCC2)C1.[Br-]","inchiKey":"FIAFMTCUJCWADZ-JOFREBOKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SOFPIRONIUM BROMIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3707224","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BBI-4000","Sofpironium bromide"],"count":1,"linkedTargets":{"rows":["ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":5},"linkedDiseases":{"rows":["HP_0000975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707370","canonicalSmiles":"CCC1(CC)C(=O)CCNC1=O","inchiKey":"RGEVWUKXWFOAID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERIDIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piperidione"],"crossReferences":{"drugbank":["DB13224"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707376","canonicalSmiles":"O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4ccc(N5C[C@H](CO)OC5=O)cc4F)CC3)c(F)cc2c1=O","inchiKey":"XWFCFMXQTBGXQW-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CADAZOLID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACT-179811","Cadazolid"],"crossReferences":{"drugbank":["DB11847"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL374731","canonicalSmiles":"Cc1cn([C@@H]2C[C@@H](O)[C@H](CO)O2)c(=O)[nH]c1=O","inchiKey":"IQFYYKKMVGJFEH-CSMHCCOUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TELBIVUDINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sebivo","Tyzeka"],"synonyms":["LDT-600","LDT600","NV-02B","Telbivudine"],"crossReferences":{"Wikipedia":["Telbivudine"],"drugbank":["DB01265"],"chEBI":["63624"]},"count":4,"approvedIndications":["EFO_0004197","EFO_0000763","EFO_0004239"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3918017","canonicalSmiles":"CC[C@@H](C(N)=O)N1C[C@H](C=C(F)F)CC1=O","inchiKey":"ANWPENAPCIFDSZ-RQJHMYQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELETRACETAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seletracetam","UCB 44212","UCB-44212"],"crossReferences":{"drugbank":["DB05885"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3989512","canonicalSmiles":"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C","inchiKey":"DZMVCVHATYROOS-ZBFGKEHZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOBLIDOTIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Soblidotin","TZT-1027"],"crossReferences":{"drugbank":["DB12677"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989682","canonicalSmiles":"CN(CP(=O)(O)O)c1cc([N+](=O)[O-])cc2[nH]c(=O)c(=O)[nH]c12","inchiKey":"DDOAQMGXVXFNSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECAMPANEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMP397","Becampanel"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989736","canonicalSmiles":"N[C@@H](Cc1cc([131I])c(Oc2cc([131I])c(O)c([131I])c2)c([131I])c1)C(=O)O","inchiKey":"XUIIKFGFIJCVMT-LRAKGTFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYROXINE I 131","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1624","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thyroxine i 131"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989780","canonicalSmiles":"O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O","inchiKey":"WXOMTJVVIMOXJL-BOBFKVMVSA-A","drugType":"Unknown","blackBoxWarning":false,"name":"SUCRALFATE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2367706","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antepsin","Carafate","Sucralfate","Ulcerlmin"],"synonyms":["Sucralfate"],"count":2,"approvedIndications":["HP_0004398","EFO_0003948"],"linkedTargets":{"rows":["ENSG00000256713"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","HP_0004398"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for gastroesophageal reflux disease and peptic ulcer."}
{"id":"CHEMBL3989829","canonicalSmiles":"CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O","inchiKey":"AGFWIZQEWFGATK-UNZHCMSXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NETILMICIN SULFATE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1572","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Netillin","Netromycin"],"synonyms":["Netilmicin sulfate","SCH 20569","SCH-20569"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983 and has 1 investigational indication."}
{"id":"CHEMBL3989861","canonicalSmiles":"CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O.O=C(O)/C=C/C(=O)O","inchiKey":"YETWCSLOYUZBLK-JITBQSAISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESVENLAFAXINE FUMARATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1118","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Desvenlafaxine fumarate"],"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989930","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1.Cl.Cl","inchiKey":"KIHHNWDWKMJZHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLMUTINIB HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3786343","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI1482694CL2","Olmutinib hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989997","drugType":"Antibody","blackBoxWarning":false,"name":"SUVRATOXUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-4893","MEDI4893","Suvratoxumab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3990045","drugType":"Unknown","blackBoxWarning":false,"name":"TASADENOTUREV","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNX-2401","Dnx-2401","Tasadenoturev"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4063154","canonicalSmiles":"O.O.O.O.O.O.O=C([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]","inchiKey":"ILRVASBWNRYBFD-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4063154","maximumClinicalTrialPhase":0,"parentId":"CHEMBL666","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4072756","canonicalSmiles":"COc1cccc([C@@H](Oc2ccc3c(cnn3-c3ccc(F)cc3)c2)[C@H](C)NC(=O)C(F)(F)F)c1","inchiKey":"FCNQMDSJHADDFT-WNSKOXEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-5423","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD5423","Azd 5423","Azd-5423","Azd5423"],"crossReferences":{"drugbank":["DB12280"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297101","canonicalSmiles":"Cc1oc(=O)oc1COC(=O)N1CC[C@@H](N2CC/C(=C\\C3=C(C(=O)[O-])N4C(=O)[C@@H](NC(=O)/C(=N/O)c5nsc(N)n5)[C@H]4SC3)C2=O)C1.[Na+]","inchiKey":"MFAWUGGPPMTWPU-INRVRKGJSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOBIPROLE MEDOCARIL","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1652606","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAL5788","BAL5788-001","Ceftobiprole medocaril","RO 65-5788"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297328","canonicalSmiles":"O=C(CN1CCOCC1)Nc1ccc(OC2CCN(C3CCC3)CC2)cc1","inchiKey":"LNXDUSQEXVQFGP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUVN-G3031","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SUVN-G3031 FREE BASE","Samelisant","Suvn-g3031"],"crossReferences":{"drugbank":["DB14835"]},"childChemblIds":["CHEMBL4593911"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297333","canonicalSmiles":"CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCC(=O)O","inchiKey":"JGGNOCUEWOGWPL-MUUNZHRXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VB-201","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vb-201"],"crossReferences":{"drugbank":["DB15259"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297630","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)O)C(C)C)C(=O)O","inchiKey":"YEKUUBPJRPXMBM-PTCFZACGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"COTADUTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cotadutide","MEDI-0382","MEDI0382","Medi 0382","Medi0382"],"crossReferences":{"drugbank":["DB15194"]},"count":4,"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297659","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC1=C(C)C(=O)c2ccccc2C1=O","inchiKey":"HYPYXGZDOYTYDR-HAJWAVTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENAQUINONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J39.473D","Menaquinone"],"crossReferences":{"drugbank":["DB15381"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297662","canonicalSmiles":"Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cn1.[Br-]","inchiKey":"WAKIMVYUBWMMHJ-FXRZFVDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARLOXOTINIB BROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4297661","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tarloxotinib bromide"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297752","drugType":"Unknown","blackBoxWarning":false,"name":"FERRIC PYROPHOSPHATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferric pyrophosphate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297811","drugType":"Protein","blackBoxWarning":false,"name":"PR1 LEUKEMIA PEPTIDE VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pr1 leukemia peptide vaccine"],"count":5,"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297823","drugType":"Unknown","blackBoxWarning":false,"name":"SC-004","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADC SC-004","SC-004","SC004","Sc-004"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297951","drugType":"Unknown","blackBoxWarning":false,"name":"COAGULATION FACTOR X HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coagulation factor x human","Factor x","Human coagulation factor x"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297987","drugType":"Antibody","blackBoxWarning":false,"name":"ENAPOTAMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enapotamab vedotin","Humax axl adc","Humax-axl-adc"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4298078","drugType":"Unknown","blackBoxWarning":false,"name":"PYRIDOXAMINE DIHYDROCHLORIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-21278","Pyridorin","Pyridoxamine dihydrochloride"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL432130","canonicalSmiles":"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1.CS(=O)(=O)O","inchiKey":"DUHQBKLTAVUXFF-FERBBOLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL432130","maximumClinicalTrialPhase":0,"parentId":"CHEMBL91829","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL434785","canonicalSmiles":"N[C@@H](C(=O)O)C1Cc2ccccc2C1","inchiKey":"GUDHMDVRURNAHL-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL434785","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04061"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL444478","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"FBSKJMQYURKNSU-ZLSOWSIRSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"ACETOSIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetoside","Acteoside","Verbacoside","Verbascoside"],"crossReferences":{"PubChem":["85201029"],"drugbank":["DB12996"],"chEBI":["9953"]},"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL447868","canonicalSmiles":"O=C([O-])c1ccccc1O.[Na+]","inchiKey":"ABBQHOQBGMUPJH-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SALICYLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alysine","Sod sal"],"synonyms":["NSC-202167","Salicylate sodium","Salicylic acid sodium salt","Sodium Salicylate","Sodium salicylate"],"crossReferences":{"PubChem":["144207609","26748246"],"Wikipedia":["Sodium_salicylate"],"chEBI":["9180"]},"count":5,"approvedIndications":["HP_0001945","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever and has 3 investigational indications."}
{"id":"CHEMBL451855","canonicalSmiles":"NC(=O)c1c[se]c([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)n1","inchiKey":"SKNBJMQZTZPCPF-QZTLEVGFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Selenazole-4-Carboxamide Adenine Dinucleotide","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Selenazole-4-Carboxamide Adenine Dinucleotide"],"crossReferences":{"drugbank":["DB03070"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594259","drugType":"Small molecule","blackBoxWarning":false,"name":"TIOMOLIBDATE CHOLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALXN-1840","ALXN1840","ATN-224","Alxn1840","Atn-224","Bis(choline) tetrathiomolybdate","Tiomolibdate choline","WTX-101","WTX101","Wtx-101","Wtx101"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594265","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"GIVOSIRAN SODIUM","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Givlaari"],"synonyms":["Givosiran sodium"],"crossReferences":{"DailyMed":["givosiran%20sodium"]},"count":1,"approvedIndications":["Orphanet_95157"],"linkedTargets":{"rows":["ENSG00000023330"],"count":1},"linkedDiseases":{"rows":["Orphanet_95157"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2019 and is indicated for acute hepatic porphyria."}
{"id":"CHEMBL4594279","canonicalSmiles":"CS(=O)(=O)O.O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1","inchiKey":"JGSYRKUPDSSTCB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRBANIBULIN MESYLATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL571546","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KX-01 Mesylate","Tirbanibulin mesylate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594380","canonicalSmiles":"[2H]c1c([2H])c([2H])c2c([nH]c(=O)n2CCCN2CCC(n3c(=O)[nH]c4cc(Cl)ccc43)CC2)c1[2H]","inchiKey":"FGXWKSZFVQUSTL-GYABSUSNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEUDOMPERIDONE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL219916","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CIN-102","Deudomperidone"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594406","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPIVOTIDE TETRAXETAN LUTETIUM LU-177","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4594730","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["177LU-LABELED PSMA-617","177lu-psma-617","Vipivotide tetraxetan lutetium lu-177"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594458","drugType":"Unknown","blackBoxWarning":false,"name":"ANTITHROMBIN GAMMA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antithrombin gamma"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594601","drugType":"Unknown","blackBoxWarning":false,"name":"RO-5429083","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG 7356","RG-7356","RO-5429083","RO5429083","Ro-5429083","Ro5429083"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL46403","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)O","inchiKey":"QIQXTHQIDYTFRH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STEARIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hystrene 5016"],"synonyms":["E570","Stearic acid"],"crossReferences":{"PubChem":["144204705","144209085","144210879","170465630","17389656","26753067","29216458"],"Wikipedia":["Stearic_acid"],"drugbank":["DB03193"],"chEBI":["28842"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL465617","canonicalSmiles":"NC12CC3CC(CC(C3)C1)C2.O=S(=O)(O)O","inchiKey":"PLRGINNCKYSSTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMANTADINE SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL660","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amantadine Sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485945","canonicalSmiles":"NCCNc1nnc(-c2ccc(F)c(F)c2Nc2ccc(I)cc2F)o1","inchiKey":"FPDWDLAITHFTTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL485945","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08130"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL513909","canonicalSmiles":"CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1","inchiKey":"XQVVPGYIWAGRNI-JOCHJYFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-2536","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI-2536","Bi 2536","Bi-2536"],"count":7,"linkedTargets":{"rows":["ENSG00000166851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003860","EFO_0000673","EFO_0000702","EFO_0000222","EFO_0000574","EFO_0003060"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL564829","canonicalSmiles":"CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2","inchiKey":"RXZMYLDMFYNEIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILCICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Milciclib","PHA 848125","PHA-848125","Pha-848125"],"childChemblIds":["CHEMBL4297668","CHEMBL561564"],"count":3,"linkedTargets":{"rows":["ENSG00000123374","ENSG00000135446","ENSG00000170312","ENSG00000198400"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000576","EFO_1000581","EFO_0000182"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL571","canonicalSmiles":"CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1","inchiKey":"DKYWVDODHFEZIM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"KETOPROFEN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actron","Alrheumat","Axorid","Fenoket 200","Jomethid xl","Ketocid 200","Ketonal","Ketoprofen","Ketotard 200 xl","Ketovail","Ketozip 200 xl","Larafen","Larafen cr","Nexcede","Orudis","Orudis 100","Orudis kt","Oruvail","Oruvail 100","Oruvail 150","Oruvail 200","Oruvail im","Powergel","Tiloket","Tiloket cr","Valket 200 retard"],"synonyms":["19583RP","IDEA-033","Ketoprofen","R.P. 19,583","R.P. 19583","RP-19583","RU-4733"],"crossReferences":{"DailyMed":["ketoprofen"],"PubChem":["11532908","144204145","144208045","170465449","26747548","50086520","50106498","85231099","857801","90341309"],"Wikipedia":["Ketoprofen"],"drugbank":["DB01009"],"chEBI":["6128"]},"childChemblIds":["CHEMBL341922"],"count":15,"approvedIndications":["HP_0002829","HP_0003326","EFO_0003843","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","EFO_0002970","MONDO_0002009","EFO_0003821","HP_0011110","Orphanet_79383","EFO_0003843","HP_0011868","EFO_0005755","HP_0002829","EFO_1001412","HP_0003326","MP_0001845","EFO_0000546","EFO_0002506","EFO_0000512","MONDO_0002471","EFO_0009582","EFO_0004253","EFO_0000649","EFO_0004888","EFO_0004616","HP_0003419","MONDO_0002258","MONDO_0004857"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL571546","canonicalSmiles":"O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1","inchiKey":"HUNGUWOZPQBXGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIRBANIBULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KX-01","KX-2-391","KX-2391","KX2-391","KX2391","Kx2-391","Tirbanibulin"],"crossReferences":{"PubChem":["164339429"],"drugbank":["DB06137"]},"childChemblIds":["CHEMBL4594279"],"count":4,"linkedTargets":{"rows":["ENSG00000197122"],"count":1},"linkedDiseases":{"rows":["EFO_0000574","EFO_0000222","MONDO_0008315","EFO_0002496"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL571987","canonicalSmiles":"CCc1nn(CCO)c(CC)c1Oc1cc(C#N)cc(C#N)c1","inchiKey":"MCPUZZJBAHRIPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LERSIVIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lersivirine","UK-453,061","UK-453061"],"crossReferences":{"drugbank":["DB11649"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL576982","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1","inchiKey":"CVWXJKQAOSCOAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUIZARTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AC-010220","AC-220","AC010220","AC220","ASP-2689","Ac-220","Quizartinib"],"crossReferences":{"PubChem":["137275856"],"drugbank":["DB12874"],"chEBI":["90217"]},"childChemblIds":["CHEMBL2105709"],"count":2,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000165731","ENSG00000113721","ENSG00000157404","ENSG00000182578","ENSG00000122025"],"count":6},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000220","EFO_0001421","EFO_0000222"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL593429","canonicalSmiles":"NC(=O)NC1NC(=O)NC1=O","inchiKey":"POJWUDADGALRAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLANTOIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Allantoin"],"crossReferences":{"PubChem":["144203946","144209285","144213229","170465460","26665884","26748398","73440"],"Wikipedia":["Allantoin"],"drugbank":["DB11100"],"chEBI":["15676"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL601719","canonicalSmiles":"C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl","inchiKey":"KTEIFNKAUNYNJU-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRIZOTINIB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xalkori"],"synonyms":["Crizotinib","PF-02341066","PF-2341066"],"crossReferences":{"DailyMed":["crizotinib"],"Wikipedia":["Crizotinib"],"drugbank":["DB08865"],"chEBI":["64310"]},"count":19,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000171094","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_1000616","EFO_0000571","MONDO_0007254","EFO_0000222","EFO_0000228","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_1001951","EFO_1000026","EFO_0000640","MONDO_0001056","EFO_0003032","MONDO_0008903","MONDO_0011962","EFO_0000574","EFO_0001378","MONDO_0015798","EFO_0000707","MONDO_0024880","Orphanet_637","EFO_0000519"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 3 approved and 16 investigational indications."}
{"id":"CHEMBL601773","canonicalSmiles":"CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O","inchiKey":"DEQITUUQPICUMR-HJPBWRTMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROERGOCRISTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydroergocristine","GNF-Pf-3462"],"crossReferences":{"PubChem":["124883203","124883205","144205574","144206666","26751531","50104109","50104110","90341070"],"drugbank":["DB13345"],"chEBI":["59912"]},"childChemblIds":["CHEMBL1255837"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL627","canonicalSmiles":"C[N+](C)([O-])CCC=C1c2ccccc2CCc2ccccc21","inchiKey":"ZPMKQFOGINQDAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMITRIPTYLINOXIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMITRYPTYLINE-N-OXIDE","Amitriptylinoxide","J9.621K"],"crossReferences":{"PubChem":["4253961"],"Wikipedia":["Amitriptylinoxide"],"drugbank":["DB13114"]},"childChemblIds":["CHEMBL1994889"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL72232","canonicalSmiles":"O=C(c1ccc(O)cc1)N1CCc2c(n(Cc3ccc(O)cc3)c3ccccc23)C1","inchiKey":"ADXYEWMDAGIULV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL72232","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04030"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76739","canonicalSmiles":"C[C@H](C(=O)O)[C@H](N)C(=O)O","inchiKey":"LXRUAYBIUSUULX-HRFVKAFMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL76739","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04538"],"chEBI":["47980"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL76768","canonicalSmiles":"O=C(O)C1=CCCNC1","inchiKey":"QTDZOWFRBNTPQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUVACINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guvacine"],"crossReferences":{"PubChem":["11111208","11113419","90340745"],"drugbank":["DB08848"],"chEBI":["5576"]},"childChemblIds":["CHEMBL1256362"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL783","canonicalSmiles":"CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1","inchiKey":"OELFLUMRDSZNSF-BRWVUGGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NATEGLINIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nateglinide","Starlix","Starsis"],"synonyms":["A-4166","AY-4166","AY4166","DJN 608","DJN-608","Nateglinide","SDZ DJN 608","SDZ-DJN-608"],"crossReferences":{"DailyMed":["nateglinide"],"PubChem":["144204985","170464822","26719880"],"drugbank":["DB00731"],"chEBI":["31897"]},"count":2,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000187486","ENSG00000006071"],"count":2},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and is indicated for type ii diabetes mellitus and diabetes mellitus."}
{"id":"CHEMBL82324","canonicalSmiles":"O=C(O)c1ccc(B(O)O)cc1","inchiKey":"SIAVMDKGVRXFAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Boronobenzoic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Boronobenzoic Acid","4-Carboxyphenylboronicacid","4-Dihydroxyboranyl-Benzoic Acid Anion","4-Phenylester Boronic Acid"],"crossReferences":{"PubChem":["26753149"],"drugbank":["DB03140"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL85860","canonicalSmiles":"CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2ccccc2)n1","inchiKey":"XIWRCSVXKPGGAJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL85860","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01807"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL870","canonicalSmiles":"NCCCC(O)(P(=O)(O)O)P(=O)(O)O","inchiKey":"OGSPWJRAVKPPFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALENDRONIC ACID","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Binosto","Fosamax"],"synonyms":["Alendronate","Alendronic Acid","Alendronic acid","Fosamax"],"crossReferences":{"DailyMed":["alendronate%20sodium"],"Wikipedia":["Alendronic_acid"],"drugbank":["DB00630"],"chEBI":["2567"]},"childChemblIds":["CHEMBL675","CHEMBL2367465"],"count":15,"approvedIndications":["EFO_0004260"],"linkedTargets":{"rows":["ENSG00000160752"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0004261","EFO_0003869","HP_0004349","Orphanet_93276","MONDO_0008170","MONDO_0007254","EFO_0003762","HP_0003418","EFO_0004197","EFO_0000266","Orphanet_666","EFO_0003882","EFO_0004260","HP_0000938","MONDO_0002050","EFO_0002506","EFO_0008506","EFO_0003854","EFO_0000649","EFO_0000270","EFO_0000764","EFO_0000673","EFO_1000882","EFO_0004259"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for bone disease and has 14 investigational indications."}
{"id":"CHEMBL87385","canonicalSmiles":"OCCN1CCN(CC/C=C2\\c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"WFPIAZLQTJBIFN-BLLMUTORSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPENTHIXOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AY-62021","Chlorpenthixol","Clopenthixol","N-746"],"crossReferences":{"PubChem":["11112430"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL89506","canonicalSmiles":"CCCCCCCCSCC(=O)C(F)(F)F","inchiKey":"WMQHRXUKAYSPPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL89506","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08612"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
